Documentos relacionados

1. In silico and in vitro assessment of drugs potentially causing adverse effects by inhibiting CYP17A1.
2. Comparative Dynamics and Functional Mechanisms of the CYP17A1 Tunnels Regulated by Ligand Binding.
3. [Clinical and genetic analysis of a patient with isolated 17,20 lyase deficiency presenting with pubertal gynecomastia].
4. Full-term live birth in a woman with 17α-hydroxylase and 17,20-lyase deficiency with assisted reproductive technology: a case report.
5. The Multienzyme Complex Nature of Dehydroepiandrosterone Sulfate Biosynthesis.
6. Identification of a homozygous c.1039C>T (p.R347C) variant in CYP17A1 in a 67-year-old female patient with partial 17α-hydroxylase/17,20-lyase deficiency.
7. Exploring the Chemical Space of CYP17A1 Inhibitors Using Cheminformatics and Machine Learning.
8. Importance of Asparagine 202 in Manipulating Active Site Structure and Substrate Preference for Human CYP17A1.
9. Proteomics, modeling, and fluorescence assays delineate cytochrome b₅ residues involved in binding and stimulation of cytochrome P450 17A1 17,20-lyase.
10. Tracking protein-protein interactions by NMR: conformational selection in human steroidogenic cytochrome P450 CYP17A1 induced by cytochrome <i>b</i>₅.